Human Health

Immuno-oncology

Improving cell therapy products

Taking advantage of our immune system is one of the most promising strategies in our fight against cancer, the second leading cause of death worldwide. In the new era of personalize medicine, it is essential to understand the genetic landscape of cancer in order to design the right tools.

Whether a solution is needed to define the neoantigen landscape of specific tumors, measure the TCR diversity present in a cell therapy product, or assess the metabolomic status (exhausted state) of a particular cell product or after a particular treatment, Eremid™’s team and capabilities can help with technical and biological expertise.

Looking for deeper insights on your next project?

Discuss a project
Looking for deeper insights on your next project? Discuss a project
"Working with Eremid has been a pleasure. We received excellent data with a very fast turnaround and appreciated the attentive and helpful project management!" Steve Watkins, BCD Biosciences, CA USA — CEO